Harvard's T-cell cancer therapy developer has filed to list on the Nasdaq Global Market.
First reported late last year, Sense Biodetection has confirmed a $50m series B round backed by Cambridge Innovation Capital.
The oat milk brand, which has filed for a $100m offering in the US, traces its origins back to Lund University in the 1990s.
General Motors led a series D round for the lithium-metal battery technology spinout of MIT formerly known as SolidEnergy Systems.
University of Louisville spinout Talaris has filed for an initial public offering on the Nasdaq Global Market.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
The CIC-backed eye disease treatment developer has filed for a $100m initial public offering, having raised over $250m in funding in the past two years.
Lumicks, which is developing single-molecule analysis technology based on research at Vrije Universiteit Amsterdam, has collected $93m.
Tectonic Therapeutic is the latest venture undertaken by Harvard’s serial entrepreneur Timothy Springer, who co-led the series A round.
Alchemab Therapeutics has raised $80m to advance research originating at University of Oxford, Johns Hopkins University and Mount Sinai Hospital.